Valuation of the largest companies in the same industry.
Industry median 0.96x
4.35x01276HENGRUI PHARMA
2.73x01177SBP GROUP
2.38x01681CONSUN PHARMA
2.24x01167JACOBIO-B
2.11x01093CSPC PHARMA
0x2x4x6x8x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 0.96x
0.00x1.00x2.00x3.00x4.00x
Current valuation
0.42xP/S
HK$0.07Share price
HK$0.17Revenue per share
Valuation history
P/SFair rangeMedian
P/S
0.93x
Fair range
0.70x–1.06x
Peer comparison
Valuation of the largest companies in the same industry.
Industry median 2.07x
4472.37x01672ASCLETIS-B
113.11x00399STARCOIN GROUP
15.65x01228CANBRIDGE-B
10.12x01276HENGRUI PHARMA
8.50x01541IMMUNEONCO-B
0x1,119x2,238x3,357x4,476x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 2.07x
0.00x1,000.00x2,000.00x3,000.00x4,000.00x
Current valuation
Valuation history
Not enough history to plot yet.
About this page
This page shows TIANDA PHARMA (00455) on four valuation measures - P/E, P/B, P/S and dividend yield: the current value, the per-share input, 1/3/5/10-year valuation history with its fair range, peer comparison within the same sub-industry, and the industry distribution. Per-share figures come from disclosed statements divided by the shares in issue that month, and each historical point uses the close of that day against the statements published by then.